GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arbutus Biopharma Corp (FRA:I9DN) » Definitions » E10

Arbutus Biopharma (FRA:I9DN) E10 : €-1.92 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Arbutus Biopharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Arbutus Biopharma's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.92 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was -9.00% per year. During the past 5 years, the average E10 Growth Rate was -8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Arbutus Biopharma was 23.00% per year. The lowest was -19.90% per year. And the median was -6.20% per year.

As of today (2025-03-24), Arbutus Biopharma's current stock price is €3.004. Arbutus Biopharma's E10 for the quarter that ended in Sep. 2024 was €-1.92. Arbutus Biopharma's Shiller PE Ratio of today is .


Arbutus Biopharma E10 Historical Data

The historical data trend for Arbutus Biopharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbutus Biopharma E10 Chart

Arbutus Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.39 -1.47 -1.57 -2.12 -2.11

Arbutus Biopharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.13 -2.11 -2.06 -2.06 -1.92

Competitive Comparison of Arbutus Biopharma's E10

For the Biotechnology subindustry, Arbutus Biopharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arbutus Biopharma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arbutus Biopharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Arbutus Biopharma's Shiller PE Ratio falls into.



Arbutus Biopharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arbutus Biopharma's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.09/133.0289*133.0289
=-0.090

Current CPI (Sep. 2024) = 133.0289.

Arbutus Biopharma Quarterly Data

per share eps CPI Adj_EPS
201412 -0.219 99.070 -0.294
201503 -0.370 99.621 -0.494
201506 -0.241 100.684 -0.318
201509 -0.508 100.392 -0.673
201512 -0.092 99.792 -0.123
201603 -0.278 100.470 -0.368
201606 -2.198 101.688 -2.875
201609 -0.330 101.861 -0.431
201612 -3.877 101.863 -5.063
201703 -0.318 102.862 -0.411
201706 -0.294 103.349 -0.378
201709 -0.176 104.136 -0.225
201712 -0.566 104.011 -0.724
201803 -0.292 105.290 -0.369
201806 0.009 106.317 0.011
201809 -0.420 106.507 -0.525
201812 -0.325 105.998 -0.408
201903 -0.416 107.251 -0.516
201906 -0.407 108.070 -0.501
201909 -1.362 108.329 -1.673
201912 -0.414 108.420 -0.508
202003 -0.226 108.902 -0.276
202006 -0.222 108.767 -0.272
202009 -0.229 109.815 -0.277
202012 -0.189 109.897 -0.229
202103 -0.176 111.754 -0.210
202106 -0.191 114.631 -0.222
202109 -0.204 115.734 -0.234
202112 -0.133 117.630 -0.150
202203 -0.100 121.301 -0.110
202206 -0.095 125.017 -0.101
202209 -0.121 125.227 -0.129
202212 -0.132 125.222 -0.140
202303 -0.093 127.348 -0.097
202306 -0.092 128.729 -0.095
202309 -0.112 129.860 -0.115
202312 -0.110 129.419 -0.113
202403 -0.092 131.776 -0.093
202406 -0.102 132.554 -0.102
202409 -0.090 133.029 -0.090

Add all the adjusted EPS together and divide 10 will get our e10.


Arbutus Biopharma  (FRA:I9DN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Arbutus Biopharma E10 Related Terms

Thank you for viewing the detailed overview of Arbutus Biopharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Arbutus Biopharma Business Description

Traded in Other Exchanges
Address
701 Veterans Circle, Warminster, PA, USA, 18974
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Arbutus Biopharma Headlines

No Headlines